Drug intelligence / Profile preview

geneticin

Development stage
Unknown
Lead developer
Micromonospora rhodorangea
Modality
Small Molecules
01

Overview

Geneticin (G418) is an aminoglycoside antibiotic structurally similar to gentamicin B1 and produced by the bacterium Micromonospora rhodorangea. It acts by binding to the 80S ribosome in both prokaryotic and eukaryotic cells, inhibiting protein synthesis at the elongation step and resulting in cell death. Resistance to Geneticin is conferred by the neo gene from Tn5 encoding aminoglycoside 3'-phosphotransferase (APH(3')II), which inactivates the drug. Geneticin is widely used as a selective agent in laboratory research for selecting genetically engineered cells that have incorporated a resistance gene; it is not approved for clinical use or therapeutic applications[2][3][6].

Brand names
Geneticin
Other names
G418 sulfateG-418 sulfateG 418 sulfategeneticin sulfateantibiotic G 418antibiotic G-418
02

Targets

30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on geneticin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on geneticin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call